GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Invictus MD Strategies Corp (OTCPK:IVITF) » Definitions » 6-1 Month Momentum %

Invictus MD Strategies (Invictus MD Strategies) 6-1 Month Momentum % : N/A% (As of Apr. 28, 2024)


View and export this data going back to 2015. Start your Free Trial

What is Invictus MD Strategies 6-1 Month Momentum %?

6-1 Month Momentum % is the total return of the stock from 6-month ago to 1-month ago. As of today (2024-04-28), Invictus MD Strategies's 6-1 Month Momentum % is N/A%.

The industry rank for Invictus MD Strategies's 6-1 Month Momentum % or its related term are showing as below:

IVITF's 6-1 Month Momentum % is not ranked *
in the Drug Manufacturers industry.
Industry Median: 3.415
* Ranked among companies with meaningful 6-1 Month Momentum % only.

Competitive Comparison of Invictus MD Strategies's 6-1 Month Momentum %

For the Drug Manufacturers - Specialty & Generic subindustry, Invictus MD Strategies's 6-1 Month Momentum %, along with its competitors' market caps and 6-1 Month Momentum % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Invictus MD Strategies's 6-1 Month Momentum % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Invictus MD Strategies's 6-1 Month Momentum % distribution charts can be found below:

* The bar in red indicates where Invictus MD Strategies's 6-1 Month Momentum % falls into.



Invictus MD Strategies  (OTCPK:IVITF) 6-1 Month Momentum % Calculation

6-1 Month Momentum % is calculated as following:

6-1 Month Momentum %=( Price 1-month ago / Price 6-month ago - 1 ) * 100 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Invictus MD Strategies  (OTCPK:IVITF) 6-1 Month Momentum % Explanation

Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 6-1 Month Momentum % measures the total return to a stock over the past six months, but ignores the previous month.

The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.


Invictus MD Strategies 6-1 Month Momentum % Related Terms

Thank you for viewing the detailed overview of Invictus MD Strategies's 6-1 Month Momentum % provided by GuruFocus.com. Please click on the following links to see related term pages.


Invictus MD Strategies (Invictus MD Strategies) Business Description

Traded in Other Exchanges
N/A
Address
595 Burrard Street, 16th floor, Vancouver, BC, CAN, V7X 1J1
Invictus MD Strategies Corp is a cannabis company with a focus on the Canadian cannabis space, offering a selection of products under a wide range of cannabinoid profiles that fit the demand of the company's medical clients and retail customers. Its wholly-owned subsidiary's Phase I and Phase II facilities are in full production. The company's 50% owned subsidiary has completed its Phase II expansion and received its amended license from Health Canada. Another of its wholly owned subsidiary, connects medical clients to physicians for medical cannabis.

Invictus MD Strategies (Invictus MD Strategies) Headlines

From GuruFocus

Invictus announces Annual General Meeting Date

By Marketwired Marketwired 06-20-2019

INVICTUS ANNOUNCES CHANGE TO BOARD

By Marketwired Marketwired 12-14-2019

ACREAGE PHARMS LTD. GRANTED OIL SALES LICENSE

By Marketwired Marketwired 08-14-2019

INVICTUS CLOSES SALE OF 0989561 BC LTD. DBA CANANDIA BIOCEUTICALS

By Marketwired Marketwired 09-24-2019

Invictus announces Annual General Meeting Results

By Marketwired Marketwired 07-25-2019

INVICTUS ANNOUNCES FIRST QUARTER FINANCIAL RESULTS

By Marketwired Marketwired 06-28-2019

Invictus announces Closing of Non-Brokered Private Placement

By Marketwired Marketwired 07-09-2019